IL1B and Alzheimer disease: Furthermore, compared with the model group, the expressions of NLRP3, caspase-1, and IL-1β were significantly decreased in the acacetin group, indicating that acacetin can inhibit the activation of NLRP3 signaling pathway in AD mice (Figure 3).